Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5128]
News [14865]
Articles [105]
Editorials [3]
Conferences [245]
elearning [21]
The Sanger Institute and personalised genomics
Dr Julia Wilson - Wellcome Trust Sanger Institue, Hinxton, UK
The Sanger Institute and personalised genomics ( Dr Julia Wilson - Wellcome Trust Sanger Institue, Hinxton, UK )
19 Dec 2017
Worrying results from genotyping quality assessments
Prof David Barton - National Centre for Medical Genetics, Dublin, Ireland
Worrying results from genotyping quality assessments ( Prof David Barton - National Centre for Medical Genetics, Dublin, Ireland )
14 Dec 2017
Focus on screening, not biomarkers
Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands
Focus on screening, not biomarkers ( Dr Hain Van Poppel - European Association of Urology, Arnhem, The Netherlands )
14 Dec 2017
Creating a culture of shared data
Prof Mark Lawler - Queen's University Belfast, Belfast, Ireland
Creating a culture of shared data ( Prof Mark Lawler - Queen's University Belfast, Belfast, Ireland )
14 Dec 2017
Developing drugs for personalised medicine
Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK
Developing drugs for personalised medicine ( Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK )
14 Dec 2017
Next generation sequencing identifies smoldering multiple myeloma patients with...
Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression ( Dr Salomon Manier - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2017
Advancements in the treatment and management of patients with castration...
Prof Kurt Miller and Prof David Dearnaley
Advancements in the treatment and management of patients with castration resistant prostate cancer ( Prof Kurt Miller and Prof David Dearnaley )
12 Dec 2017
Venetoclax plus rituximab for patients with relapsed / refractory CLL
Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Venetoclax plus rituximab for patients with relapsed / refractory CLL ( Prof John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia )
12 Dec 2017
Daratumumab for patients with multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Daratumumab for patients with multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
12 Dec 2017
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib...
Prof Meletios Dimopoulos - National and Kapodistrian University of Athens...
Daratumumab plus bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone for multiple myeloma ( Prof Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )
12 Dec 2017
ASH 2017: Immunotherapy for multiple myeloma
Prof Paul Richardson & Dr Wenming Chen
ASH 2017: Immunotherapy for multiple myeloma ( Prof Paul Richardson & Dr Wenming Chen )
12 Dec 2017
Multiple myeloma highlights from ASH 2017
Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey
Multiple myeloma highlights from ASH 2017 ( Prof Meral Beksac - Ankara University Medical School, Ankara, Turkey )
12 Dec 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation